Results of a double-blind, placebo-controlled study to evaluate treatment of obese adolescents with sibutramine - Efficacy and safety

被引：0

|

作者：

Berkowitz, R

Fujioka, K

Hewkin, A

Walch, J

Peng, J

Blakesley, V

Renz, C

机构：

来源：

OBESITY RESEARCH | 2004年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A28 / A29

页数：2

相关论文

共 50 条

[1] Echocardiogram results from a double-blind, placebo-controlled study to evaluate the safety and efficacy of sibutramine in the treatment of obese adolescents
Fujioka, K
Gordon, S
Hewkin, A
Blakesley, V
[J]. DIABETES, 2005, 54 : A438 - A438
[2] Dyslipidemia in obese adolescents: A double-blind, placebo-controlled study to evaluate treatment with sibutramine
Berkowitz, R
Hazan, L
Jasinsky, O
Blakesley, V
[J]. OBESITY RESEARCH, 2005, 13 : A26 - A27
[3] Results of a double-blind, placebo-controlled study to evaluate treatment of obese adolescents with sibutramine - Lipid effects
Fennoy, I
Berkowitz, R
Gordon, S
Hewkin, A
Blakesley, V
[J]. DIABETES, 2005, 54 : A438 - A438
[4] Results of a double-blind, placebo-controlled study to evaluate treatment of obese adolescents with sibutramine - Mood and QoL
Berkowitz, R
Perry, A
Hewkin, A
Jasinsky, O
Renz, C
[J]. OBESITY RESEARCH, 2004, 12 : A49 - A49
[5] Metabolic syndrome in obese adolescents in a double-blind, placebo-controlled study to evaluate treatment with sibutramine
Daniels, S
Caprio, S
Hewkin, A
Blakesley, V
[J]. CIRCULATION, 2005, 112 (17) : U908 - U909
[6] Demographics: Waist circumference of obese adolescents in a double-blind, placebo-controlled study to evaluate sibutramine treatment
Fujioka, K
Smith, D
Walch, J
Blakesley, V
[J]. OBESITY RESEARCH, 2005, 13 : A192 - A192
[7] Cardiovascular effects of sibutramine in the treatment of obese adolescents: Results of a randomized, double-blind, placebo-controlled study
Daniels, Stephen R.
Long, Barbara
Crow, Scott
Styne, Dennis
Sothern, Melinda
Vargas-Rodriguez, Ileana
Harris, Lisa
Walch, Julia
Jasinsky, Olga
Cwik, Kristine
Hewkin, Ann
Blakesley, Vicky
[J]. PEDIATRICS, 2007, 120 (01) : E147 - E157
[8] Demographics: Prevalence of metabolic syndrome in obese adolescents from a double-blind, placebo-controlled study to evaluate treatment with sibutramine
Daniels, S
Pierson, M
Hewkin, A
Blakesley, V
[J]. OBESITY RESEARCH, 2005, 13 : A133 - A133
[9] Results of a double-blind, placebo-controlled study to evaluate treatment of obese adolescents with sibutramine-mean change in vital signs by BMI responder category
Long, B
Crow, S
Hewkin, A
Blakesley, V
[J]. DIABETES, 2005, 54 : A437 - A437
[10] Results of a double-blind, placebo-controlled study to evaluate treatment of obese adolescents with sibutramine - Blood pressure, pulse rate, 24-hour ABPM measurements
Daniels, S
Loar, A
Cwik, K
Blakesley, V
Renz, C
[J]. OBESITY RESEARCH, 2004, 12 : A50 - A50

← 1 2 3 4 5 →